Key result
Wild ginseng CMCs reduce body weight and lipid levels in high-fat diet-fed mice.
Why the study?
The protective mechanisms of wild ginseng cambial meristematic cells on non-alcoholic fatty liver disease in high-fat diet-fed mice were not determined.
Does wild ginseng CMCs improve hepatic steatosis and mitochondrial dysfunction in high-fat diet-fed mice?
Does wild ginseng CMCs improve hepatic steatosis and mitochondrial dysfunction in high-fat diet-fed mice?
Wild ginseng CMCs protect against high-fat diet-induced liver injury by preventing lipid accumulation and mitochondrial oxidative stress, and enhancing mitochondrial biogenesis in a mouse model.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for wild ginseng CMCs in murine steatosis; leaves open translation to human metabolic liver disease.
OBJECTIVES: The aim of this study was to determine the protective mechanisms of wild ginseng cambial meristematic cells (CMCs) on non-alcoholic fatty liver disease in high-fat diet (HFD)-fed mice. METHODS: Male C57BL/6 mice received either normal-fat diet or HFD for 10 weeks along with wild ginseng CMCs (75, 150 and 300 mg/kg) or vehicle (0.5% carboxyl methyl cellulose) by oral administration once a day. Triglyceride and total cholesterol contents were measured in liver and serum samples. Parameters for hepatic lipid metabolism and mitochondria biogenesis were assessed. KEY FINDINGS: Treatment with wild ginseng CMCs markedly attenuated body weight, serum and hepatic lipid contents, and serum aminotransferase activity. While wild ginseng CMCs attenuated the increases in sterol regulatory element-binding transcription factor 1 (SREBP-1) and carbohydrate-responsive element-binding protein (ChREBP) expression, it enhanced the increases in carnitine palmitoyltransferase 1A (CPT1A) and peroxisome proliferator-activated receptor alpha (PPAR-α) expression. HFD decreased glutamate dehydrogenase activity and glutathione content, and increased lipid peroxidation, which were all attenuated by wild ginseng CMCs. Furthermore, wild ginseng CMCs enhanced mitochondrial biogenesis-related factors, including peroxisome proliferator-activated receptor-γ co activator 1α (PGC1α), nuclear respiratory factor 1 (NRF1) and mitochondrial transcription factor A (TFAM). CONCLUSIONS: Wild ginseng CMCs protect against HFD-induced liver injury, which prevents lipid accumulation and mitochondrial oxidative stress, and enhances mitochondrial biogenesis.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2016) studied Non-alcoholic fatty liver disease. Wild ginseng cambial meristematic cells (CMCs) vs. Vehicle (0.5% carboxyl methyl cellulose) was evaluated on Body weight, serum and hepatic lipid contents, and serum aminotransferase activity. Treatment with wild ginseng CMCs markedly attenuated body weight, serum and hepatic lipid contents, and serum aminotransferase activity in high-fat diet-fed mice.
Synapse has enriched 10 related papers. Consider them for comparative context: